Ventris Medical Awarded U.S. Patent
The patented technology, which will be commercialized as Amplify granules, will become a major component of Ventris' synthetic bone graft...
Jul 08, 2024,
Orthobiologics
ORTHOFLASH 
Biogennix Shares Study Results for TrelCor Bone Graft Material
The results showed that TrelCor exhibited a robust bioactive response and was capable of stimulating bone forming cells....
Jun 13, 2024,
Breakthrough Device Designation for Infuse Bone Graft
This designation addresses Infuse in a TLIF approach in the treatment of degenerative disease of the lumbosacral spine....
May 30, 2024,
5,000 Patients Treated with OssDsign Catalyst in the U.S.
Catalyst nanosynthetic bone graft stimulates the formation of healthy bone tissue in spinal fusion surgeries....
May 30, 2024,
Isto Biologics Debuts Fibrant Liberty Allograft
Upon hydration, the graft transforms into a pliable form that can be tailored to meet precise needs of diverse surgical...
May 09, 2024,
Biogennix Gains 510(k) for Moldable Bone Grafts
Expanded indications for Agilon Moldable and Morpheus Moldable address use in the intervertebral disc space as an autograft extender....
May 09, 2024,
Enrollment Complete in Lipogems ARISE I Study
Lipogems completed enrollment in the ARISE I FDA IDE study examining MicroFat vs. corticosteriod injection for the treatment of knee...
Apr 10, 2024,
Lipogems Enrolls 2nd Trial for Knee Osteoarthritis
The first patient is enrolled in ARISE II, an IDE research study to examine investigational MicroFat vs. saline injection to...
Apr 08, 2024,
GID BIO Completes Enrollment for Cell Therapy Study
GID BIO completed enrollment for the first of two pivotal Phase III studies to investigate the use of your own...
Mar 26, 2024,
CERAMENT G Gains FDA 510(k) for Open Fracture Treatment
BONESUPPORT's CERAMENT G is an orthopedic medical device combination matrix comprising a resorbable synthetic bone graft substitute and the antibiotic...
Mar 14, 2024,
Loading new posts...
No more posts
